文献速递消化内镜胃肠动力与功能性疾病

胰高血糖素样肽-1受体激动剂与糖尿病患者胶囊内镜检查:一项匹配队列研究

Glucagon-like peptide-1 receptor agonists and capsule endoscopy in patients with diabetes: a matched cohort study.
PubMed 文献 · Gastrointest Endosc · 2024-07-31

这项回顾性匹配队列研究纳入糖尿病患者,比较使用与不使用GLP-1RA者的视频胶囊内镜结局。GLP-1RA组胃转运时间更长,胶囊未通过胃和小肠未完全评估的比例更高。作者认为未来研究可能对评估减轻这些影响的策略至关重要。

要点

  • GLP-1RA组胃转运时间99.3±134.2分钟,对照组25.3±31.6分钟(P<.001)。
  • GLP-1RA组5例(7%)胶囊未通过胃,对照组全部通过(P=.06)。
  • GLP-1RA组16例(23.5%)小肠未完全通过,对照组3例(4.4%,P<.01)。

核心结论

  • GLP-1RA使用与视频胶囊内镜检查中胃转运时间延长及小肠不完全评估率升高相关。
  • 作者认为未来研究可能对评估减轻这些影响的策略至关重要。

研究设计与样本

  • 回顾性队列研究,糖尿病患者按人口学和糖尿病相关因素1:1匹配,GLP-1RA组68例,对照组为不使用GLP-1RA者。

主要发现

  • GLP-1RA组5例(7%)胶囊未通过胃,对照组全部成功通过(P=.06)。
  • GLP-1RA组胃转运时间99.3±134.2分钟,对照组25.3±31.6分钟(P<.001)。
  • 多因素分析显示,调整相关因素后,GLP-1RA使用与胃转运时间增加74.5分钟相关(95%CI 33.8-115.2;P<.001)。
  • GLP-1RA组16例(23.5%)胶囊未完全通过小肠,对照组3例(4.4%,P<.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Video capsule endoscopy (VCE) is valuable for assessing conditions like GI bleeding, anemia, and inflammatory bowel disease. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are prescribed for diabetes and weight loss, with their pharmacologic effects including delayed gastric emptying. This study investigates the impact of GLP-1RA use on VCE outcomes in patients with diabetes. METHODS: This retrospective cohort study involves patients with diabetes undergoing VCE while on GLP-1RAs matched in a 1:1 ratio with control subjects, who are not on GLP-1RAs, based on demographics and diabetes-related factors. The primary outcome was gastric transit time in VCE studies, whereas secondary outcomes were incomplete small-bowel evaluation and small-bowel transit time. RESULTS: In the GLP-1RA cohort with 68 patients, 5 (7%) experienced failure to pass the video capsule through the stomach; all control subjects passed the video capsule successfully (P = .06). GLP-1RA patients had a longer gastric transit time (99.3 ± 134.2 minutes) compared with control subjects (25.3 ± 31.6 minutes, P < .001). Multivariate analysis revealed GLP-1RA use was associated with an increased gastric transit time by 74.5 minutes (95% confidence interval, 33.8-115.2; P < .001) compared with control subjects, after adjusting for relevant factors. Sixteen GLP-1RA patients (23.5%) experienced incomplete passage of the video capsule through the small intestine, a significantly higher rate compared with 3 patients in the control group (4.4%, P < .01). CONCLUSIONS: GLP-1RA use is associated with a prolonged gastric transit time and a higher rate of incomplete small-bowel evaluation during VCE. Future studies may be crucial for evaluating strategies to mitigate these effects.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Odah T, Vattikonda A, Stark M, et al. Glucagon-like peptide-1 receptor agonists and capsule endoscopy in patients with diabetes: a matched cohort study. Gastrointest Endosc. 2024. PMID: 39094916. doi:10.1016/j.gie.2024.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。